Abbott's combo drug lowers LDL better than simvastatin alone
Tuesday, November 06, 2007 18:00 IST Orlando, Florida
Abbott announced that the new data released recently showed that its Simcor, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan, and simvastatin met its primary endpoint
